Circulating miR-21 levels in hypertensive patients with asymptomatic organ damage

Medicine (Baltimore). 2019 Sep;98(39):e17297. doi: 10.1097/MD.0000000000017297.

Abstract

As a modifiable risk factor for cardiovascular disease, presence of hypertension (HT) necessitates the awareness of asymptomatic organ damage (AOD). The aim of this study was to measure plasma micro RNA-21 (miR-21) and the parameters that reflect AOD such as carotid intima-media thickness (CIMT), microalbuminuria (MAU) in hypertensive patients compared with healthy controls. In addition, the aim of this study was to evaluate plasma miR-21 levels in HT patients with AOD.This study was designed as a cross-sectional observational study. The study includes 2 groups: 32 patients with HT and 32 healthy controls. First, we compared these 2 groups. Then, to underline the relationship between plasma miR-21 and HT, hypertensive patients were divided into 2 groups: with AOD and without AOD.Sixteen patients with HT had AOD. MiR-21 levels significantly correlated with clinical systolic and diastolic blood pressure, MAU, C-reactive protein, and CIMT. CIMT, miR-21, and MAU levels were significantly higher in patients with AOD.Our study showed increased miR-21 levels in HT patients with AOD.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Albuminuria* / diagnosis
  • Albuminuria* / etiology
  • Asymptomatic Diseases / epidemiology
  • Blood Pressure / physiology
  • C-Reactive Protein / analysis
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / etiology
  • Carotid Intima-Media Thickness
  • Circulating MicroRNA / analysis
  • Correlation of Data
  • Cross-Sectional Studies
  • Female
  • Humans
  • Hypertension* / complications
  • Hypertension* / diagnosis
  • Hypertension* / genetics
  • Hypertension* / physiopathology
  • Male
  • MicroRNAs / blood*
  • Middle Aged
  • Turkey / epidemiology

Substances

  • Circulating MicroRNA
  • MIRN21 microRNA, human
  • MicroRNAs
  • C-Reactive Protein